Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06062329 · ClinicalTrials.gov registry record · NA
SYMPHONY-PE Study for Treatment of Pulmonary Embolism
A NA study, sponsored by Imperative Care.
- Completed
- Registry status
- NA
- Development phase
- 109
- Enrollment target
NCT06062329: Completed NA study, sponsored by Imperative Care.
NCT06062329 is a NA study that has completed, run by Imperative Care. The registered enrollment target is 109 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06062329, a NA study, has completed, sponsored by Imperative Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 109 participants
- Enrollment target
Study Summary
Evaluation of the Safety and Efficacy of the Symphony Thrombectomy System in the Treatment of Pulmonary Embolism
Primary Outcome
A composite of all-cause major bleeding, device-related mortality, device-related serious adverse events
Interventions
- DEVICE Symphony Thrombectomy System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2023-12-13 |
| Est. Completion | 2025-05-29 |
| Phase | NA |
What the finished NCT06062329 record still lists
NCT06062329 is an interventional study that assigns participants to a tested intervention. The registered 109 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which Symphony Thrombectomy System is the first listed.
NCT06062329 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06062329 about?
NCT06062329 is a clinical study titled "SYMPHONY-PE Study for Treatment of Pulmonary Embolism". Evaluation of the Safety and Efficacy of the Symphony Thrombectomy System in the Treatment of Pulmonary Embolism
What is the current status of trial NCT06062329?
This trial is currently completed. It is a NA study. The enrollment target is 109 participants. The study started on 2023-12-13. Estimated completion is 2025-05-29.
What interventions are being tested in trial NCT06062329?
The interventions under investigation include: Symphony Thrombectomy System (DEVICE).
Who is sponsoring clinical trial NCT06062329?
This trial is sponsored by Imperative Care, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06062329's enrollment target sits among peer trials
109 825th of 2000 higher than 1,176 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02421380 · 109 participants · NA
Characterization of Hyperpolarized Pyruvate MRI Reproducibility
- NCT04526600 · 109 participants · NA
Fidgeting and Attentional and Emotional Regulation in ADHD
- NCT04835584 · 109 participants · Phase 1
KRT-232 and TKI Study in Chronic Myeloid Leukemia
- NCT06626516 · 109 participants · Phase 1
Tebentafusp-tebn With LDT in Metastatic UM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI